Search
for
Sort by
Research 30 of 121
- Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
- Antigen presenting cells in the skin of a patient with hair loss and systemic lupus erythematosus.
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- The Dynamics of the Skin’s Immune System
- Interrelation of immunity and tissue repair or regeneration
- Dermatophytosis in companion animals: A review
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Choreographing Immunity in the Skin Epithelial Barrier
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Chitosan/LiCl composite scaffolds promote skin regeneration in full-thickness loss
- Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review)
- Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Acne is a medical and social problem
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database